Automatic attentional shifts induced by a noradrenergic drug in Alzheimer's disease: Evidence from evoked potentials

International Journal of Psychophysiology

Volumn 33, Issue 3, 1999, Pages 243-251

  Missonnier, Pascal ^a   Ragot, Richard ^a   Derouesné, Christian ^a   Guez, David ^b   Renault, Bernard ^a  

^a Centre National de la Recherche Scientifique   (France)

^b IRIS Institut de Recherches Internationales Servier   (France)

Author keywords

Alzheimer's disease (AD); Automatic orienting reflex; Automatic processes; Event related potentials (ERPs); Noradrenergic drug; Selective attention

Indexed keywords

1,2,3,4 TETRAHYDRO 1 METHYL 8 (2 MORPHOLINYLMETHOXY)QUINOLINE; PLACEBO;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION; AUTONOMIC NERVOUS SYSTEM; BEHAVIOR; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DICHOTIC LISTENING; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EVENT RELATED POTENTIAL; FEMALE; HUMAN; MALE; MENTAL PERFORMANCE; NORADRENALIN RELEASE; NORADRENERGIC SYSTEM; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC AGENTS; AGED; ALZHEIMER DISEASE; ATTENTION; CEREBRAL CORTEX; COGNITION DISORDERS; CROSS-OVER STUDIES; DISCRIMINATION (PSYCHOLOGY); DOUBLE-BLIND METHOD; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHOLINES; MULTIVARIATE ANALYSIS; NOOTROPIC AGENTS; NOREPINEPHRINE; PERCEPTUAL MASKING; QUINOLINES; VOLITION;

EID: 0032864760     PISSN: 01678760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8760(99)00059-8     Document Type: Article

References (41)

1. Allain H., Neuman E., Malbezin M., Salzman V., Guez D., Wesnes K., Gandon J.M. Brindings study of S12024 in 53 in-patients with Alzheimer's disease. J. Am. Geriatr. Soc. 45:1997;125-126.
2. Brown W.S., Marsh J.T., LaRue A. Event-related potentials in psychiatry: Differentiating depression and dementia in the elderly. Bull. Los Angel. Neurol. Soc. 47:1982;91-107.
3. Coleman P.D., Flood D.G. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol. Aging. 8:1987;521-545.
4. Escera C., Alho K., Winkler I., Näätänen R. Neural mechanisms of involuntary attention to acoustic novelty and change. J. Cogn. Neurosci. 5:1998;590-604.
5. Folstein M.F., Folstein S.E., McHugh P.R. 'Mini-Mental State'. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:1975;189-198.
6. Giard M.-H., Lavikainen J., Reinikainen K., Perrin F., Bertrand O., Thèvenet M., Pernier J., Näätänen R. Separate representation of stimulus frequency, intensity and duration in auditory sensory memory: An event-related potential and dipole-model analysis. J. Cogn. Neurosci. 7:1995;133-143.
7. Goodin D.S., Squires K.C., Starr A. Long latency event-related components of the auditory evoked potential in dementia. Brain. 101:1978;635-648.
8. Gratton G., Coles M.G., Donchin E. A new method for off-line removal of ocular artifact. Electroencephalogr. Clin. Neurophysiol. 55:1983;468-484.
9. Griffin M.G., Taylor G.T. Norepinephrine modulation of social memory: evidence for a time-dependent functional recovery of behavior. Behav. Neurosci. 109:1995;466-473.
10. Guez D., Neuman E., Malbezin M. Pharmacodynamic and early clinical studies with S12024 in Alzheimer's disease. Levy R., Howard R. Developments in Dementia and Functional Disorders in the Elderly. 1995;69-75 Wrightson Biomedical Publishing Ltd, Petersfield, UK and Bristol USA.
11. Hachinski V.C., Iliff L.D., Zilhka E. et al. Cerebral blood flow in dementia. Arch. Neurol. 32:1975;632-637.
12. Hansen J.C., Hillyard S.A. Endogenous brain potentials associated with selective auditory attention. Electroencephalogr. Clin. Neurophysiol. 49:1980;277-290.
13. Ito J., Yamao S., Fukuda H., Mimori Y., Nakamura S. The P300 event-related potentials in dementia of Alzheimer type correlations between P300 and monoamine metabolites. Electroencephalogr. Clin. Neurophysiol. 77:1990;174-178.
14. Iversen L.L., Rossor M.N., Reynolds G.P. Loss of pigmented dopamine-5-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer type. Neurosci. Lett. 39:1983;95-100.
15. Knight R.T. Neural mechanisms of event-related potentials: evidence from human lesion studies. Rohrbaugh J., Parasuraman R., Johnson R. Event-Related Brain Potentials: Basic Issues and Applications. 1990;3-18 Oxford University Press, New York.
16. Knight R.T. Contribution of human hippocampal region to novelty detection. Nature. 383:1996;256-259.
17. Knight R.T. Distributed cortical network for visual attention. J. Cogn. Neurosci. 9:1997;75-91.
18. Lepagnol, J.M., Lestage, P., 1994. Memory-enhancing effects of S12024: Involvement of vasopressinergic neurotransmission. 3rd International Springfield Symposium on Advances in Alzheimer Therapy. Springfield, IL, 11-15 May.
19. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of health and human services task force on Alzheimer's disease. Neurology. 34:1984;939-944.
20. Mesulam M.-M. Principles of Behavioral Neurology. 1985;F.A. Davies, Philadelphia.
21. Morrison J.H., Foote S.L. Noradrenergic and serotoninergic innervation of cortical, thalamic and tectal structures in old and new world monkeys. J. Comp. Neurol. 143:1986;117-118.
22. Näätänen R. Processing negativity: An evoked-potential reflection of selective attention. Psychol. Bull. 92:1982;605-640.
23. Näätänen R. Selective attention and stimulus processing: Reflections in event-related potentials, magnetoencephalogram and regional blood flow. Posner M.I., Marin O.S.M. Attention and Performance XI. 1985;355-373 Lawrence Erlbaum, NJ.
24. Näätänen R. The role of attention in auditory information processing as revealed by event-related potentials and other brain measures of cognitive function. Behav. Brain. Sci. 13:1990;201-288.
25. Näätänen R. Attention and Brain Function. 1992;Lawrence Erlbaum, Hillsdale, NJ.
26. Näätänen R., Gaillard A.W.K. The orienting reflex and the N2 deflection of the event-related potential (ERP). Gaillard A.W.K., Ritter W. Tutorials in Event-Related Potentials Research: Endogenous Components. 1983;119-142 Elsevier, Amsterdam.
27. Näätänen R., Gaillard A.W., Mäntysalo S. Early selective-attention effect on evoked potential reinterpreted. Acta. Psychol. 42:1978;313-329.
28. Palmer A.M., Wilcock G.K., Esiri M.M., Francis P.T., Bowen D.M. Monoaminergic innervation of frontal and temporal lobes in Alzheimer's disease. Brain Res. 401:1987;231-238.
29. Pekkonen E., Jousmäki V., kononen M., Reinikainen K., Partanen J. Auditory sensory memory impairment in Alzheimer's disease: An event-related potential study. NeuroReport. 5:1994;2537-2540.
30. Pezard L., Martinerie J., Varela F.J. et al. Entropy maps characterize drug effects on brain dynamics in Alzheimer's disease. Neurosci. Lett. 253:1998;5-8.
31. Pineda J.A., Swick D., Foote S.L. Noradrenergic and cholinergic influences on the genesis of P3-like potentials. Brunia C.H.M., Mulder G., Verbaten M.N. Event-Related Brain Research. (Suppl 42 to Electroencephalography and Clinical Neurophysiology). 1991;165-172 Elsevier, Amsterdam.
32. Polich J. P300 evaluation of aging and dementia. Brunia C.H.M., Mulder G., Verbaten M.N. Event-Related Brain Research. (Suppl 42 to Electroencephalography and Clinical Neurophysiology). 1991;304-323 Elsevier, Amsterdam.
33. Polich J., Ladish C., Bloom F.E. P300 assessment of early Alzheimer's disease. Electroencephalogr. Clin. Neurophysiol. 77:1990;179-189.
34. Polich J., Kok A. Cognitive and biological determinants of P300: An integrative review. Biol. Psychol. 41:1995;103-146.
35. Rossor M., Iversen L.L. Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease. Br. Med. Bull. 42:1986;70-74.
36. Squires N.K., Squires K.C., Hillyard S.A. Two varieties of long-latency positive waves evoked by unpredictable auditory stimuli in man. Electroencephalogr. Clin. Neurophysiol. 38:1975;387-401.
37. Stroop J.R. Studies of interference in serial verbal reactions. J. Exp. Psychol. 18:1935;643-662.
38. Tiitinen H., Alho K., Huotilainen M., Ilmoniemi R.J., Simola J., Näätänen R. Tonotopic auditory cortex and the magnetoencephalographic (MEG) equivalent of the mismatch negativity. Psychophysiology. 30:1993;537-540.
39. Wesnes K., Neuman E., de Wilde H.J.G. et al. Pharmacodynamic effects of repeated oral administration of 4 different doses of S12024-2 (cognitive enhancer) in 36 healthy volunteers. Neurobiol. Aging. 15(Suppl. 1):1994;S100.
40. Wilcock G.K., Esiri M.M., Bowen D.M., Hughes A.O. The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type. J. Neurol. Neurosurg. Psychiatry. 51:1988;842-849.
41. Williams P.A., Jones G.H., Briscoe M., Thomas R., Cronin P. P300 and reaction-time measures in senile dementia of the Alzheimer type. Br. J. Psychiatry. 159:1991;410-414.